Elutia Inc.
ELUT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708527
No open-market purchases or sales by Elutia Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Elutia Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 17 | 17 | 0 |
| Shares | 3.29M | 3.34M | +54.4K (+1.7%) |
| Value | $19.4M | $23.6M | +$4.22M (+21.8%) |
New holders (1)
Institutions that held Elutia Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 10,275 | $72.0K | 0.00% |
Sold out (1)
Institutions that held Elutia Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Tower Research Capital LLC (TRC) | 1,204 | $7.00K |